Breakdown | ||||
TTM | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
17.05M | 16.68M | 9.83M | 2.55M | 0.00 | Gross Profit |
2.20M | 3.55M | 2.55M | 829.29K | 0.00 | EBIT |
-9.18M | -7.19M | -3.52M | -1.05M | -5.52K | EBITDA |
-9.17M | -10.84M | -2.91M | -977.46K | 0.00 | Net Income Common Stockholders |
-14.44M | -14.79M | -4.91M | -1.33M | -5.52K |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
21.97K | 178.96K | 444.25K | 2.06M | 21.97K | Total Assets |
0.00 | 21.79M | 20.19M | 6.33M | 21.97K | Total Debt |
0.00 | 18.42M | 23.61M | 6.69M | 0.00 | Net Debt |
21.97K | 18.24M | 23.17M | 4.64M | -21.97K | Total Liabilities |
0.00 | 22.58M | 25.32M | 7.20M | 0.00 | Stockholders Equity |
21.97K | -788.26K | -5.14M | -869.09K | 21.97K |
Cash Flow | Free Cash Flow | |||
-10.31M | -4.20M | -2.84M | -2.32M | -5.52K | Operating Cash Flow |
-10.08M | -3.82M | -2.66M | -1.01M | -5.52K | Investing Cash Flow |
-1.71M | -1.87M | -14.67M | -4.02M | 0.00 | Financing Cash Flow |
10.72M | 5.63M | 15.71M | 7.07M | 269.16K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $73.04B | 29.84 | 50.91% | 1.10% | 8.33% | 7.70% | |
73 Outperform | $33.70B | 38.99 | 57.66% | ― | 6.46% | 5.82% | |
65 Neutral | $5.15B | 15.34 | 5.49% | ― | 0.50% | ― | |
59 Neutral | $12.26B | 11.12 | -0.55% | 3.78% | 1.42% | -20.63% | |
38 Underperform | $3.91M | ― | -502.92% | ― | 6.12% | 70.51% |
On January 22, 2025, Inspire Veterinary Partners, Inc. announced a 1-for-25 reverse stock split of its Class A common stock, effective January 27, 2025. This move is intended to help the company comply with Nasdaq’s $1.00 minimum bid price requirement to maintain its listing. The reverse stock split will not affect any stockholder’s percentage interest in the company’s equity, and all changes will be uniformly applied.